These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 27343849

  • 1. De novo noncutaneous malignancies after kidney transplantation are associated with an increased risk of graft failure: results from a time-dependent analysis on 672 patients.
    Cena T, Musetti C, Quaglia M, Magnani C, Stratta P, Bagnardi V, Cantaluppi V.
    Transpl Int; 2016 Oct; 29(10):1085-93. PubMed ID: 27343849
    [Abstract] [Full Text] [Related]

  • 2. Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial.
    Favi E, Spagnoletti G, Salerno MP, Pedroso JA, Romagnoli J, Citterio F.
    Clin Transplant; 2013 Oct; 27(4):E359-67. PubMed ID: 23710603
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combined introduction of anti-IL2 receptor antibodies, mycophenolic acid and tacrolimus: effect on malignancies after renal transplantation in a single-centre retrospective cohort study.
    Braconnier P, Del Marmol V, Broeders N, Kianda M, Massart A, Lemy A, Ghisdal L, Le Moine A, Madhoun P, Racapé J, Abramowicz D, Wissing KM.
    Nephrol Dial Transplant; 2012 Jun; 27(6):2547-53. PubMed ID: 22123748
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Early immunosuppression treatment correlates with later de novo donor-specific antibody development after kidney and pancreas transplantation.
    Pelletier RP, Rajab AA, Diez A, DiPaola NR, Bumgardner GL, Elkhammas EA, Henry ML.
    Clin Transplant; 2015 Dec; 29(12):1119-27. PubMed ID: 26382932
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Rejection after simultaneous pancreas-kidney transplantation.
    Arbogast H, Malaise J, Illner WD, Tarabichi A, Dieterle C, Landgraf R, Land W, Euro-SPK Study Group.
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii11-7, ii62. PubMed ID: 15814544
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
    Gallon LG, Winoto J, Chhabra D, Parker MA, Leventhal JR, Kaufman DB.
    Transplantation; 2007 May 27; 83(10):1324-9. PubMed ID: 17519781
    [Abstract] [Full Text] [Related]

  • 17. Adherence in patients in the first year after kidney transplantation and its impact on graft loss and mortality: a cross-sectional and prospective study.
    Prihodova L, Nagyova I, Rosenberger J, Majernikova M, Roland R, Groothoff JW, van Dijk JP.
    J Adv Nurs; 2014 Dec 27; 70(12):2871-83. PubMed ID: 24853863
    [Abstract] [Full Text] [Related]

  • 18. Donor positive blood culture is associated with delayed graft function in kidney transplant recipients: a propensity score analysis of the UNOS database.
    Huaman MA, Vilchez V, Mei X, Davenport D, Gedaly R.
    Clin Transplant; 2016 Apr 27; 30(4):415-20. PubMed ID: 26840885
    [Abstract] [Full Text] [Related]

  • 19. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
    Jaber JJ, Feustel PJ, Elbahloul O, Conti AD, Gallichio MH, Conti DJ.
    Clin Transplant; 2007 Apr 27; 21(1):101-9. PubMed ID: 17302598
    [Abstract] [Full Text] [Related]

  • 20. A 39-month follow-up study to evaluate the safety and efficacy in kidney transplant recipients treated with modified-release tacrolimus (FK506E)-based immunosuppression regimen.
    Han DJ, Park JB, Kim YS, Kim SJ, Ha J, Kim HC, Kim SJ, Moon IS, Yang CW.
    Transplant Proc; 2012 Jan 27; 44(1):115-7. PubMed ID: 22310592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.